Irreversible electroporation promising in pancreatic cancer

September 4, 2015

Irreversible electroporation promising in pancreatic cancer
(HealthDay)—Irreversible electroporation (IRE) in pancreatic cancer cells may improve survival rates for some patients, new research suggests. The findings were published in the September issue of the Annals of Surgery.

Robert Martin II, M.D., Ph.D., director of at the University of Louisville in Kentucky, and colleagues included patients with locally-advanced pancreatic cancer, making complete surgical removal impossible. All of the 200 adults with stage III pancreatic cancer included in the current study underwent electrical IRE treatment after completing chemotherapy.

About half of the patients in the study experienced complications. But the side effects related to IRE were minimal, according to Martin. Any side effects were "directly related to the surgical procedure" required to make the tumor area accessible, he told HealthDay. The average survival was two years. The study authors followed some patients for as long as seven years.

"For patients with locally-advanced (stage III), the addition of IRE to conventional chemotherapy and radiation therapy results in substantially prolonged survival compared with historical controls," the authors write. "These results suggest that ablative control of the primary tumor may prolong survival."

Explore further: CT-guided irreversible electroporation safe in unresectable pancreatic carcinoma

More information: Full Text (subscription or payment may be required)

Related Stories

CT-guided irreversible electroporation safe in unresectable pancreatic carcinoma

May 7, 2014
A small group of patients with locally advanced unresectable pancreatic carcinoma suffered no major ill effects—pancreatitis or fistula formation—after undergoing percutaneous CT-guided irreversible electroporation (IRE)—a ...

Study finds genes associated with improved survival for pancreatic cancer patients

August 20, 2015
A study by the Translational Genomics Research Institute (TGen) and other major research institutes, found a new set of genes that can indicate improved survival after surgery for patients with pancreatic cancer. The study ...

Electrical pulse treatment gives pancreatic cancer patients new hope

March 26, 2012
Results of a study presented at the Society of Interventional Radiology's 37th Annual Scientific Meeting in San Francisco, Calif., signal a light at the end of the tunnel for individuals with inoperable locally advanced pancreatic ...

Chemotherapy and SABR consecutively may be promising treatment option for advanced pancreatic cancer

September 16, 2014
For patients with locally advanced pancreatic cancer, the combination of chemotherapy and stereotactic ablative radiation (SABR) may be a promising treatment option, ultimately allowing them to undergo surgery that may not ...

Stereotactic body radiation therapy appears to help some patients with pancreatic cancer

May 18, 2015
Two studies from Johns Hopkins Kimmel Cancer Center researchers add to preliminary evidence that high-dose radiation treatment, called stereotactic body radiotherapy, appears to be safe and as effective as standard radiation ...

Intraperitoneal chemotherapy ups ovarian cancer outcomes

August 5, 2015
(HealthDay)—Intraperitoneal chemotherapy significantly improves survival among women with advanced ovarian cancer; however, fewer than half of eligible U.S. patients are receiving it, according to research published online ...

Recommended for you

'Druggable' cancer target found in pathway regulating organ size

November 20, 2018
It's known that cancer involves unchecked cell growth and that a biological pathway that regulates organ size, known at the Hippo pathway, is also involved in cancer. It's further known that a major player in this pathway, ...

A study suggests that epigenetic treatments could trigger the development of aggressive tumours

November 20, 2018
A study headed by the Institute for Research in Biomedicine (IRB Barcelona) and published in the journal Nature Cell Biology examined whether the opening of chromatin (a complex formed by DNA bound to proteins) is the factor ...

Redefining colorectal cancer subtypes

November 20, 2018
There is a long-standing belief that colorectal cancer (CRC), which causes some 50,000 deaths in the United States each year, can be categorized into distinct molecular subtypes. In a paper published recently in the journal Genome ...

Proposed cancer treatment may boost lung cancer stem cells, study warns

November 20, 2018
Epigenetic therapies—targeting enzymes that alter what genes are turned on or off in a cell—are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant. Researchers at Boston ...

New drug discovery could halt spread of brain cancer

November 19, 2018
The tissues in our bodies largely are made of fluid. It moves around cells and is essential to normal body function.

A molecule for fighting muscular paralysis

November 19, 2018
Myotubular myopathy is a severe genetic disease that leads to muscle paralysis from birth and results in death before two years of age. Although no treatment currently exists, researchers from the University of Geneva (UNIGE), ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.